Literature DB >> 2456114

The effects of prenylamine on single ventricular myocytes of guinea-pig.

Y Shimoni1, P Posner, A J Spindler, D Noble.   

Abstract

1. The action of prenylamine, an antianginal drug, was studied in single ventricular guinea-pig myocytes. In concentrations of 10-50 microM, prenylamine significantly (P less than 0.01) shortened action potentials, and significantly (P less than 0.001) reduced the inward calcium current by 29% to 76% (n = 7). This effect was also present in the presence of adrenoceptor-blockade (with phentolamine and propranolol), and was thus not due to indirect changes in endogenous catecholamine action. 2. Prenylamine did not affect the steady state level of current at the end of long pulses, and does therefore not act by changing time-dependent outward currents. Since the resting potential in the unclamped mode is unchanged during gross changes in action potential duration, it is also unlikely that there are any changes in the background, time-independent potassium conductance. 3. It is concluded that prenylamine has a direct effect on cardiac calcium channels, not mediated by adrenoceptor activation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2456114      PMCID: PMC1853998          DOI: 10.1111/j.1476-5381.1988.tb11533.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  21 in total

1.  Effects of prenylamine on cardiac membrane currents and contractility.

Authors:  H G Haas; R Kern; C Benninger; H M Einwächter
Journal:  J Pharmacol Exp Ther       Date:  1975-03       Impact factor: 4.030

2.  A rapid technique for the isolation and purification of adult cardiac muscle cells having respiratory control and a tolerance to calcium.

Authors:  T Powell; V W Twist
Journal:  Biochem Biophys Res Commun       Date:  1976-09-07       Impact factor: 3.575

Review 3.  Inward current related to contraction in guinea-pig ventricular myocytes.

Authors:  D Fedida; D Noble; Y Shimoni; A J Spindler
Journal:  J Physiol       Date:  1987-04       Impact factor: 5.182

4.  Histochemical studies on the uptake of noradrenaline and alpha-methyl-noradrenaline in the perfused rat heart.

Authors:  L O Farnebo; T Malmfors
Journal:  Eur J Pharmacol       Date:  1969-03       Impact factor: 4.432

5.  The haemodynamic and metabolic effects of MG 8926, a prospective antidysrhythmic and antianginal agent.

Authors:  R J Marshall; J R Parratt
Journal:  Br J Pharmacol       Date:  1977-02       Impact factor: 8.739

6.  A double-blind, double cross-over trial of prenylamine in angina pectoris.

Authors:  R Winsor; K Bleifer; S Cole; I R Goldman; H Karpman; R Oblath; S Stone
Journal:  Am Heart J       Date:  1971-07       Impact factor: 4.749

7.  Transient inward current underlying arrhythmogenic effects of cardiotonic steroids in Purkinje fibres.

Authors:  W J Lederer; R W Tsien
Journal:  J Physiol       Date:  1976-12       Impact factor: 5.182

8.  Alpha adrenergic contributions to dysrhythmia during myocardial ischemia and reperfusion in cats.

Authors:  D J Sheridan; P A Penkoske; B E Sobel; P B Corr
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

9.  The effect of prenylamine (segontin) on the amine levels of brain, heart and adrenal medulla in rats.

Authors:  H O Obianwu
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1965

10.  Effect of phentolamine, alprenolol and prenylamine on maximum rate of rise of action potential in guinea-pig papillary muscles.

Authors:  H Sada
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-10       Impact factor: 3.000

View more
  2 in total

1.  Biphasic effects of intra-accumbens histamine administration on spontaneous motor activity in the rat; a role for central histamine receptors.

Authors:  L J Bristow; G W Bennett
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

Review 2.  Withdrawal of prenylamine: perspectives on pharmacological, clinical and regulatory outcomes following the first QT-related casualty.

Authors:  Rashmi R Shah; Peter D Stonier
Journal:  Ther Adv Drug Saf       Date:  2018-06-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.